FDA Inspection 858888 — Osteogenics Biomedical, Inc.

Osteogenics Biomedical, Inc. — FEI 3002253367

The FDA completed an inspection of Osteogenics Biomedical, Inc. on Dec 10, 2013 in Lubbock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 10, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Lubbock, TX (United States)